Wegovy (semaglutide 2.4 mg): Dr Kovil said, Wegovy (the higher-dose version of semaglutide) is designed more for people who struggle with obesity or have weight-related health issues
In the SELECT trial, patients did not enroll for the specific purpose of weight loss and received standard of care covering management of CV risk factors, including medical treatment and healthy lifestyle counseling, but without a specific focus on weight loss
Experimental or investigational : Medications considered experimental or investigational, lacking clinical evidence
But compounding pharmacies counter that Novo Nordisks patents apply to finished medicines like Ozempic, not to the chemical that makes up semaglutide
Prioritizing lean proteins, along with whole grains, fruits, and vegetables, creates a balanced diet that supports the bodys needs